Global Seasonal Affective Disorder Therapeutics Market Growth (Status and Outlook) 2025-2031
According to this study, the global Seasonal Affective Disorder Therapeutics market size will reach US$ million by 2031.
Seasonal affective disorder (SAD) is a mood disorder subset in which people who have normal mental health throughout most of the year exhibit depressive symptoms at the same time each year, most commonly in the winter. Common symptoms include sleeping too much, having little to no energy, and overeating. The condition in the summer can include heightened anxiety.
United States market for Seasonal Affective Disorder Therapeutics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Seasonal Affective Disorder Therapeutics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Seasonal Affective Disorder Therapeutics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Seasonal Affective Disorder Therapeutics players cover Allergan, Pfizer, Roche, Eli Lily, GlaxoSmithKline, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Seasonal Affective Disorder Therapeutics Industry Forecast” looks at past sales and reviews total world Seasonal Affective Disorder Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Seasonal Affective Disorder Therapeutics sales for 2025 through 2031. With Seasonal Affective Disorder Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Seasonal Affective Disorder Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Seasonal Affective Disorder Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Seasonal Affective Disorder Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Seasonal Affective Disorder Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Seasonal Affective Disorder Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Seasonal Affective Disorder Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Seasonal Affective Disorder Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Seasonal affective disorder (SAD) is a mood disorder subset in which people who have normal mental health throughout most of the year exhibit depressive symptoms at the same time each year, most commonly in the winter. Common symptoms include sleeping too much, having little to no energy, and overeating. The condition in the summer can include heightened anxiety.
United States market for Seasonal Affective Disorder Therapeutics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Seasonal Affective Disorder Therapeutics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Seasonal Affective Disorder Therapeutics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Seasonal Affective Disorder Therapeutics players cover Allergan, Pfizer, Roche, Eli Lily, GlaxoSmithKline, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Seasonal Affective Disorder Therapeutics Industry Forecast” looks at past sales and reviews total world Seasonal Affective Disorder Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Seasonal Affective Disorder Therapeutics sales for 2025 through 2031. With Seasonal Affective Disorder Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Seasonal Affective Disorder Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Seasonal Affective Disorder Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Seasonal Affective Disorder Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Seasonal Affective Disorder Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Seasonal Affective Disorder Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Seasonal Affective Disorder Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Seasonal Affective Disorder Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Light Therapy (Phototherapy)
- Medication
- Others
- Hospitals
- Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Allergan
- Pfizer
- Roche
- Eli Lily
- GlaxoSmithKline
- Teva Pharmaceuticals
- Bausch Health Companies
- Mylan
- Sanofi
- Novartis
- Johnson & Johnson
- Koninklijke Philips
- Beurer GmbH
- Lucimed (Luminette)
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Seasonal Affective Disorder Therapeutics Market Size (2020-2031)
2.1.2 Seasonal Affective Disorder Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Seasonal Affective Disorder Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Seasonal Affective Disorder Therapeutics Segment by Type
2.2.1 Light Therapy (Phototherapy)
2.2.2 Medication
2.2.3 Others
2.3 Seasonal Affective Disorder Therapeutics Market Size by Type
2.3.1 Seasonal Affective Disorder Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Seasonal Affective Disorder Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Seasonal Affective Disorder Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Seasonal Affective Disorder Therapeutics Market Size by Application
2.5.1 Seasonal Affective Disorder Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Seasonal Affective Disorder Therapeutics Market Size Market Share by Application (2020-2025)
3 SEASONAL AFFECTIVE DISORDER THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Seasonal Affective Disorder Therapeutics Market Size Market Share by Player
3.1.1 Global Seasonal Affective Disorder Therapeutics Revenue by Player (2020-2025)
3.1.2 Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Seasonal Affective Disorder Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SEASONAL AFFECTIVE DISORDER THERAPEUTICS BY REGION
4.1 Seasonal Affective Disorder Therapeutics Market Size by Region (2020-2025)
4.2 Global Seasonal Affective Disorder Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Seasonal Affective Disorder Therapeutics Market Size Growth (2020-2025)
4.4 APAC Seasonal Affective Disorder Therapeutics Market Size Growth (2020-2025)
4.5 Europe Seasonal Affective Disorder Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Seasonal Affective Disorder Therapeutics Market Size by Country (2020-2025)
5.2 Americas Seasonal Affective Disorder Therapeutics Market Size by Type (2020-2025)
5.3 Americas Seasonal Affective Disorder Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Seasonal Affective Disorder Therapeutics Market Size by Region (2020-2025)
6.2 APAC Seasonal Affective Disorder Therapeutics Market Size by Type (2020-2025)
6.3 APAC Seasonal Affective Disorder Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Seasonal Affective Disorder Therapeutics Market Size by Country (2020-2025)
7.2 Europe Seasonal Affective Disorder Therapeutics Market Size by Type (2020-2025)
7.3 Europe Seasonal Affective Disorder Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Seasonal Affective Disorder Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SEASONAL AFFECTIVE DISORDER THERAPEUTICS MARKET FORECAST
10.1 Global Seasonal Affective Disorder Therapeutics Forecast by Region (2026-2031)
10.1.1 Global Seasonal Affective Disorder Therapeutics Forecast by Region (2026-2031)
10.1.2 Americas Seasonal Affective Disorder Therapeutics Forecast
10.1.3 APAC Seasonal Affective Disorder Therapeutics Forecast
10.1.4 Europe Seasonal Affective Disorder Therapeutics Forecast
10.1.5 Middle East & Africa Seasonal Affective Disorder Therapeutics Forecast
10.2 Americas Seasonal Affective Disorder Therapeutics Forecast by Country (2026-2031)
10.2.1 United States Market Seasonal Affective Disorder Therapeutics Forecast
10.2.2 Canada Market Seasonal Affective Disorder Therapeutics Forecast
10.2.3 Mexico Market Seasonal Affective Disorder Therapeutics Forecast
10.2.4 Brazil Market Seasonal Affective Disorder Therapeutics Forecast
10.3 APAC Seasonal Affective Disorder Therapeutics Forecast by Region (2026-2031)
10.3.1 China Seasonal Affective Disorder Therapeutics Market Forecast
10.3.2 Japan Market Seasonal Affective Disorder Therapeutics Forecast
10.3.3 Korea Market Seasonal Affective Disorder Therapeutics Forecast
10.3.4 Southeast Asia Market Seasonal Affective Disorder Therapeutics Forecast
10.3.5 India Market Seasonal Affective Disorder Therapeutics Forecast
10.3.6 Australia Market Seasonal Affective Disorder Therapeutics Forecast
10.4 Europe Seasonal Affective Disorder Therapeutics Forecast by Country (2026-2031)
10.4.1 Germany Market Seasonal Affective Disorder Therapeutics Forecast
10.4.2 France Market Seasonal Affective Disorder Therapeutics Forecast
10.4.3 UK Market Seasonal Affective Disorder Therapeutics Forecast
10.4.4 Italy Market Seasonal Affective Disorder Therapeutics Forecast
10.4.5 Russia Market Seasonal Affective Disorder Therapeutics Forecast
10.5 Middle East & Africa Seasonal Affective Disorder Therapeutics Forecast by Region (2026-2031)
10.5.1 Egypt Market Seasonal Affective Disorder Therapeutics Forecast
10.5.2 South Africa Market Seasonal Affective Disorder Therapeutics Forecast
10.5.3 Israel Market Seasonal Affective Disorder Therapeutics Forecast
10.5.4 Turkey Market Seasonal Affective Disorder Therapeutics Forecast
10.6 Global Seasonal Affective Disorder Therapeutics Forecast by Type (2026-2031)
10.7 Global Seasonal Affective Disorder Therapeutics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Seasonal Affective Disorder Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Allergan
11.1.1 Allergan Company Information
11.1.2 Allergan Seasonal Affective Disorder Therapeutics Product Offered
11.1.3 Allergan Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Allergan Main Business Overview
11.1.5 Allergan Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Seasonal Affective Disorder Therapeutics Product Offered
11.2.3 Pfizer Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Seasonal Affective Disorder Therapeutics Product Offered
11.3.3 Roche Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Roche Main Business Overview
11.3.5 Roche Latest Developments
11.4 Eli Lily
11.4.1 Eli Lily Company Information
11.4.2 Eli Lily Seasonal Affective Disorder Therapeutics Product Offered
11.4.3 Eli Lily Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Eli Lily Main Business Overview
11.4.5 Eli Lily Latest Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Seasonal Affective Disorder Therapeutics Product Offered
11.5.3 GlaxoSmithKline Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 GlaxoSmithKline Main Business Overview
11.5.5 GlaxoSmithKline Latest Developments
11.6 Teva Pharmaceuticals
11.6.1 Teva Pharmaceuticals Company Information
11.6.2 Teva Pharmaceuticals Seasonal Affective Disorder Therapeutics Product Offered
11.6.3 Teva Pharmaceuticals Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Teva Pharmaceuticals Main Business Overview
11.6.5 Teva Pharmaceuticals Latest Developments
11.7 Bausch Health Companies
11.7.1 Bausch Health Companies Company Information
11.7.2 Bausch Health Companies Seasonal Affective Disorder Therapeutics Product Offered
11.7.3 Bausch Health Companies Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Bausch Health Companies Main Business Overview
11.7.5 Bausch Health Companies Latest Developments
11.8 Mylan
11.8.1 Mylan Company Information
11.8.2 Mylan Seasonal Affective Disorder Therapeutics Product Offered
11.8.3 Mylan Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Mylan Main Business Overview
11.8.5 Mylan Latest Developments
11.9 Sanofi
11.9.1 Sanofi Company Information
11.9.2 Sanofi Seasonal Affective Disorder Therapeutics Product Offered
11.9.3 Sanofi Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Sanofi Main Business Overview
11.9.5 Sanofi Latest Developments
11.10 Novartis
11.10.1 Novartis Company Information
11.10.2 Novartis Seasonal Affective Disorder Therapeutics Product Offered
11.10.3 Novartis Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Novartis Main Business Overview
11.10.5 Novartis Latest Developments
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Information
11.11.2 Johnson & Johnson Seasonal Affective Disorder Therapeutics Product Offered
11.11.3 Johnson & Johnson Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Johnson & Johnson Main Business Overview
11.11.5 Johnson & Johnson Latest Developments
11.12 Koninklijke Philips
11.12.1 Koninklijke Philips Company Information
11.12.2 Koninklijke Philips Seasonal Affective Disorder Therapeutics Product Offered
11.12.3 Koninklijke Philips Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Koninklijke Philips Main Business Overview
11.12.5 Koninklijke Philips Latest Developments
11.13 Beurer GmbH
11.13.1 Beurer GmbH Company Information
11.13.2 Beurer GmbH Seasonal Affective Disorder Therapeutics Product Offered
11.13.3 Beurer GmbH Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Beurer GmbH Main Business Overview
11.13.5 Beurer GmbH Latest Developments
11.14 Lucimed (Luminette)
11.14.1 Lucimed (Luminette) Company Information
11.14.2 Lucimed (Luminette) Seasonal Affective Disorder Therapeutics Product Offered
11.14.3 Lucimed (Luminette) Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Lucimed (Luminette) Main Business Overview
11.14.5 Lucimed (Luminette) Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Seasonal Affective Disorder Therapeutics Market Size (2020-2031)
2.1.2 Seasonal Affective Disorder Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Seasonal Affective Disorder Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Seasonal Affective Disorder Therapeutics Segment by Type
2.2.1 Light Therapy (Phototherapy)
2.2.2 Medication
2.2.3 Others
2.3 Seasonal Affective Disorder Therapeutics Market Size by Type
2.3.1 Seasonal Affective Disorder Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Seasonal Affective Disorder Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Seasonal Affective Disorder Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Seasonal Affective Disorder Therapeutics Market Size by Application
2.5.1 Seasonal Affective Disorder Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Seasonal Affective Disorder Therapeutics Market Size Market Share by Application (2020-2025)
3 SEASONAL AFFECTIVE DISORDER THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Seasonal Affective Disorder Therapeutics Market Size Market Share by Player
3.1.1 Global Seasonal Affective Disorder Therapeutics Revenue by Player (2020-2025)
3.1.2 Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Seasonal Affective Disorder Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SEASONAL AFFECTIVE DISORDER THERAPEUTICS BY REGION
4.1 Seasonal Affective Disorder Therapeutics Market Size by Region (2020-2025)
4.2 Global Seasonal Affective Disorder Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Seasonal Affective Disorder Therapeutics Market Size Growth (2020-2025)
4.4 APAC Seasonal Affective Disorder Therapeutics Market Size Growth (2020-2025)
4.5 Europe Seasonal Affective Disorder Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Seasonal Affective Disorder Therapeutics Market Size by Country (2020-2025)
5.2 Americas Seasonal Affective Disorder Therapeutics Market Size by Type (2020-2025)
5.3 Americas Seasonal Affective Disorder Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Seasonal Affective Disorder Therapeutics Market Size by Region (2020-2025)
6.2 APAC Seasonal Affective Disorder Therapeutics Market Size by Type (2020-2025)
6.3 APAC Seasonal Affective Disorder Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Seasonal Affective Disorder Therapeutics Market Size by Country (2020-2025)
7.2 Europe Seasonal Affective Disorder Therapeutics Market Size by Type (2020-2025)
7.3 Europe Seasonal Affective Disorder Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Seasonal Affective Disorder Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SEASONAL AFFECTIVE DISORDER THERAPEUTICS MARKET FORECAST
10.1 Global Seasonal Affective Disorder Therapeutics Forecast by Region (2026-2031)
10.1.1 Global Seasonal Affective Disorder Therapeutics Forecast by Region (2026-2031)
10.1.2 Americas Seasonal Affective Disorder Therapeutics Forecast
10.1.3 APAC Seasonal Affective Disorder Therapeutics Forecast
10.1.4 Europe Seasonal Affective Disorder Therapeutics Forecast
10.1.5 Middle East & Africa Seasonal Affective Disorder Therapeutics Forecast
10.2 Americas Seasonal Affective Disorder Therapeutics Forecast by Country (2026-2031)
10.2.1 United States Market Seasonal Affective Disorder Therapeutics Forecast
10.2.2 Canada Market Seasonal Affective Disorder Therapeutics Forecast
10.2.3 Mexico Market Seasonal Affective Disorder Therapeutics Forecast
10.2.4 Brazil Market Seasonal Affective Disorder Therapeutics Forecast
10.3 APAC Seasonal Affective Disorder Therapeutics Forecast by Region (2026-2031)
10.3.1 China Seasonal Affective Disorder Therapeutics Market Forecast
10.3.2 Japan Market Seasonal Affective Disorder Therapeutics Forecast
10.3.3 Korea Market Seasonal Affective Disorder Therapeutics Forecast
10.3.4 Southeast Asia Market Seasonal Affective Disorder Therapeutics Forecast
10.3.5 India Market Seasonal Affective Disorder Therapeutics Forecast
10.3.6 Australia Market Seasonal Affective Disorder Therapeutics Forecast
10.4 Europe Seasonal Affective Disorder Therapeutics Forecast by Country (2026-2031)
10.4.1 Germany Market Seasonal Affective Disorder Therapeutics Forecast
10.4.2 France Market Seasonal Affective Disorder Therapeutics Forecast
10.4.3 UK Market Seasonal Affective Disorder Therapeutics Forecast
10.4.4 Italy Market Seasonal Affective Disorder Therapeutics Forecast
10.4.5 Russia Market Seasonal Affective Disorder Therapeutics Forecast
10.5 Middle East & Africa Seasonal Affective Disorder Therapeutics Forecast by Region (2026-2031)
10.5.1 Egypt Market Seasonal Affective Disorder Therapeutics Forecast
10.5.2 South Africa Market Seasonal Affective Disorder Therapeutics Forecast
10.5.3 Israel Market Seasonal Affective Disorder Therapeutics Forecast
10.5.4 Turkey Market Seasonal Affective Disorder Therapeutics Forecast
10.6 Global Seasonal Affective Disorder Therapeutics Forecast by Type (2026-2031)
10.7 Global Seasonal Affective Disorder Therapeutics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Seasonal Affective Disorder Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Allergan
11.1.1 Allergan Company Information
11.1.2 Allergan Seasonal Affective Disorder Therapeutics Product Offered
11.1.3 Allergan Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Allergan Main Business Overview
11.1.5 Allergan Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Seasonal Affective Disorder Therapeutics Product Offered
11.2.3 Pfizer Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Seasonal Affective Disorder Therapeutics Product Offered
11.3.3 Roche Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Roche Main Business Overview
11.3.5 Roche Latest Developments
11.4 Eli Lily
11.4.1 Eli Lily Company Information
11.4.2 Eli Lily Seasonal Affective Disorder Therapeutics Product Offered
11.4.3 Eli Lily Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Eli Lily Main Business Overview
11.4.5 Eli Lily Latest Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Seasonal Affective Disorder Therapeutics Product Offered
11.5.3 GlaxoSmithKline Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 GlaxoSmithKline Main Business Overview
11.5.5 GlaxoSmithKline Latest Developments
11.6 Teva Pharmaceuticals
11.6.1 Teva Pharmaceuticals Company Information
11.6.2 Teva Pharmaceuticals Seasonal Affective Disorder Therapeutics Product Offered
11.6.3 Teva Pharmaceuticals Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Teva Pharmaceuticals Main Business Overview
11.6.5 Teva Pharmaceuticals Latest Developments
11.7 Bausch Health Companies
11.7.1 Bausch Health Companies Company Information
11.7.2 Bausch Health Companies Seasonal Affective Disorder Therapeutics Product Offered
11.7.3 Bausch Health Companies Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Bausch Health Companies Main Business Overview
11.7.5 Bausch Health Companies Latest Developments
11.8 Mylan
11.8.1 Mylan Company Information
11.8.2 Mylan Seasonal Affective Disorder Therapeutics Product Offered
11.8.3 Mylan Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Mylan Main Business Overview
11.8.5 Mylan Latest Developments
11.9 Sanofi
11.9.1 Sanofi Company Information
11.9.2 Sanofi Seasonal Affective Disorder Therapeutics Product Offered
11.9.3 Sanofi Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Sanofi Main Business Overview
11.9.5 Sanofi Latest Developments
11.10 Novartis
11.10.1 Novartis Company Information
11.10.2 Novartis Seasonal Affective Disorder Therapeutics Product Offered
11.10.3 Novartis Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Novartis Main Business Overview
11.10.5 Novartis Latest Developments
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Information
11.11.2 Johnson & Johnson Seasonal Affective Disorder Therapeutics Product Offered
11.11.3 Johnson & Johnson Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Johnson & Johnson Main Business Overview
11.11.5 Johnson & Johnson Latest Developments
11.12 Koninklijke Philips
11.12.1 Koninklijke Philips Company Information
11.12.2 Koninklijke Philips Seasonal Affective Disorder Therapeutics Product Offered
11.12.3 Koninklijke Philips Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Koninklijke Philips Main Business Overview
11.12.5 Koninklijke Philips Latest Developments
11.13 Beurer GmbH
11.13.1 Beurer GmbH Company Information
11.13.2 Beurer GmbH Seasonal Affective Disorder Therapeutics Product Offered
11.13.3 Beurer GmbH Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Beurer GmbH Main Business Overview
11.13.5 Beurer GmbH Latest Developments
11.14 Lucimed (Luminette)
11.14.1 Lucimed (Luminette) Company Information
11.14.2 Lucimed (Luminette) Seasonal Affective Disorder Therapeutics Product Offered
11.14.3 Lucimed (Luminette) Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Lucimed (Luminette) Main Business Overview
11.14.5 Lucimed (Luminette) Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Seasonal Affective Disorder Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Seasonal Affective Disorder Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Light Therapy (Phototherapy)
Table 4. Major Players of Medication
Table 5. Major Players of Others
Table 6. Seasonal Affective Disorder Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Seasonal Affective Disorder Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Seasonal Affective Disorder Therapeutics Market Size Market Share by Type (2020-2025)
Table 9. Seasonal Affective Disorder Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Seasonal Affective Disorder Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Seasonal Affective Disorder Therapeutics Market Size Market Share by Application (2020-2025)
Table 12. Global Seasonal Affective Disorder Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Player (2020-2025)
Table 14. Seasonal Affective Disorder Therapeutics Key Players Head office and Products Offered
Table 15. Seasonal Affective Disorder Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Seasonal Affective Disorder Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Seasonal Affective Disorder Therapeutics Market Size Market Share by Region (2020-2025)
Table 20. Global Seasonal Affective Disorder Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Seasonal Affective Disorder Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Seasonal Affective Disorder Therapeutics Market Size Market Share by Country (2020-2025)
Table 24. Americas Seasonal Affective Disorder Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Seasonal Affective Disorder Therapeutics Market Size Market Share by Type (2020-2025)
Table 26. Americas Seasonal Affective Disorder Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Seasonal Affective Disorder Therapeutics Market Size Market Share by Application (2020-2025)
Table 28. APAC Seasonal Affective Disorder Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Seasonal Affective Disorder Therapeutics Market Size Market Share by Region (2020-2025)
Table 30. APAC Seasonal Affective Disorder Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Seasonal Affective Disorder Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Seasonal Affective Disorder Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Seasonal Affective Disorder Therapeutics Market Size Market Share by Country (2020-2025)
Table 34. Europe Seasonal Affective Disorder Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Seasonal Affective Disorder Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Seasonal Affective Disorder Therapeutics
Table 40. Key Market Challenges & Risks of Seasonal Affective Disorder Therapeutics
Table 41. Key Industry Trends of Seasonal Affective Disorder Therapeutics
Table 42. Global Seasonal Affective Disorder Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Seasonal Affective Disorder Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Seasonal Affective Disorder Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Seasonal Affective Disorder Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Allergan Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 47. Allergan Seasonal Affective Disorder Therapeutics Product Offered
Table 48. Allergan Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Allergan Main Business
Table 50. Allergan Latest Developments
Table 51. Pfizer Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 52. Pfizer Seasonal Affective Disorder Therapeutics Product Offered
Table 53. Pfizer Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Pfizer Main Business
Table 55. Pfizer Latest Developments
Table 56. Roche Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 57. Roche Seasonal Affective Disorder Therapeutics Product Offered
Table 58. Roche Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Roche Main Business
Table 60. Roche Latest Developments
Table 61. Eli Lily Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 62. Eli Lily Seasonal Affective Disorder Therapeutics Product Offered
Table 63. Eli Lily Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Eli Lily Main Business
Table 65. Eli Lily Latest Developments
Table 66. GlaxoSmithKline Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 67. GlaxoSmithKline Seasonal Affective Disorder Therapeutics Product Offered
Table 68. GlaxoSmithKline Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. GlaxoSmithKline Main Business
Table 70. GlaxoSmithKline Latest Developments
Table 71. Teva Pharmaceuticals Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 72. Teva Pharmaceuticals Seasonal Affective Disorder Therapeutics Product Offered
Table 73. Teva Pharmaceuticals Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Teva Pharmaceuticals Main Business
Table 75. Teva Pharmaceuticals Latest Developments
Table 76. Bausch Health Companies Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 77. Bausch Health Companies Seasonal Affective Disorder Therapeutics Product Offered
Table 78. Bausch Health Companies Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Bausch Health Companies Main Business
Table 80. Bausch Health Companies Latest Developments
Table 81. Mylan Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 82. Mylan Seasonal Affective Disorder Therapeutics Product Offered
Table 83. Mylan Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Mylan Main Business
Table 85. Mylan Latest Developments
Table 86. Sanofi Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 87. Sanofi Seasonal Affective Disorder Therapeutics Product Offered
Table 88. Sanofi Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Sanofi Main Business
Table 90. Sanofi Latest Developments
Table 91. Novartis Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 92. Novartis Seasonal Affective Disorder Therapeutics Product Offered
Table 93. Novartis Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Novartis Main Business
Table 95. Novartis Latest Developments
Table 96. Johnson & Johnson Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 97. Johnson & Johnson Seasonal Affective Disorder Therapeutics Product Offered
Table 98. Johnson & Johnson Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Johnson & Johnson Main Business
Table 100. Johnson & Johnson Latest Developments
Table 101. Koninklijke Philips Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 102. Koninklijke Philips Seasonal Affective Disorder Therapeutics Product Offered
Table 103. Koninklijke Philips Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Koninklijke Philips Main Business
Table 105. Koninklijke Philips Latest Developments
Table 106. Beurer GmbH Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 107. Beurer GmbH Seasonal Affective Disorder Therapeutics Product Offered
Table 108. Beurer GmbH Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Beurer GmbH Main Business
Table 110. Beurer GmbH Latest Developments
Table 111. Lucimed (Luminette) Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 112. Lucimed (Luminette) Seasonal Affective Disorder Therapeutics Product Offered
Table 113. Lucimed (Luminette) Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Lucimed (Luminette) Main Business
Table 115. Lucimed (Luminette) Latest Developments
Table 1. Seasonal Affective Disorder Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Seasonal Affective Disorder Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Light Therapy (Phototherapy)
Table 4. Major Players of Medication
Table 5. Major Players of Others
Table 6. Seasonal Affective Disorder Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Seasonal Affective Disorder Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Seasonal Affective Disorder Therapeutics Market Size Market Share by Type (2020-2025)
Table 9. Seasonal Affective Disorder Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Seasonal Affective Disorder Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Seasonal Affective Disorder Therapeutics Market Size Market Share by Application (2020-2025)
Table 12. Global Seasonal Affective Disorder Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Player (2020-2025)
Table 14. Seasonal Affective Disorder Therapeutics Key Players Head office and Products Offered
Table 15. Seasonal Affective Disorder Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Seasonal Affective Disorder Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Seasonal Affective Disorder Therapeutics Market Size Market Share by Region (2020-2025)
Table 20. Global Seasonal Affective Disorder Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Seasonal Affective Disorder Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Seasonal Affective Disorder Therapeutics Market Size Market Share by Country (2020-2025)
Table 24. Americas Seasonal Affective Disorder Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Seasonal Affective Disorder Therapeutics Market Size Market Share by Type (2020-2025)
Table 26. Americas Seasonal Affective Disorder Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Seasonal Affective Disorder Therapeutics Market Size Market Share by Application (2020-2025)
Table 28. APAC Seasonal Affective Disorder Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Seasonal Affective Disorder Therapeutics Market Size Market Share by Region (2020-2025)
Table 30. APAC Seasonal Affective Disorder Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Seasonal Affective Disorder Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Seasonal Affective Disorder Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Seasonal Affective Disorder Therapeutics Market Size Market Share by Country (2020-2025)
Table 34. Europe Seasonal Affective Disorder Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Seasonal Affective Disorder Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Seasonal Affective Disorder Therapeutics
Table 40. Key Market Challenges & Risks of Seasonal Affective Disorder Therapeutics
Table 41. Key Industry Trends of Seasonal Affective Disorder Therapeutics
Table 42. Global Seasonal Affective Disorder Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Seasonal Affective Disorder Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Seasonal Affective Disorder Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Seasonal Affective Disorder Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Allergan Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 47. Allergan Seasonal Affective Disorder Therapeutics Product Offered
Table 48. Allergan Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Allergan Main Business
Table 50. Allergan Latest Developments
Table 51. Pfizer Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 52. Pfizer Seasonal Affective Disorder Therapeutics Product Offered
Table 53. Pfizer Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Pfizer Main Business
Table 55. Pfizer Latest Developments
Table 56. Roche Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 57. Roche Seasonal Affective Disorder Therapeutics Product Offered
Table 58. Roche Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Roche Main Business
Table 60. Roche Latest Developments
Table 61. Eli Lily Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 62. Eli Lily Seasonal Affective Disorder Therapeutics Product Offered
Table 63. Eli Lily Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Eli Lily Main Business
Table 65. Eli Lily Latest Developments
Table 66. GlaxoSmithKline Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 67. GlaxoSmithKline Seasonal Affective Disorder Therapeutics Product Offered
Table 68. GlaxoSmithKline Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. GlaxoSmithKline Main Business
Table 70. GlaxoSmithKline Latest Developments
Table 71. Teva Pharmaceuticals Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 72. Teva Pharmaceuticals Seasonal Affective Disorder Therapeutics Product Offered
Table 73. Teva Pharmaceuticals Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Teva Pharmaceuticals Main Business
Table 75. Teva Pharmaceuticals Latest Developments
Table 76. Bausch Health Companies Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 77. Bausch Health Companies Seasonal Affective Disorder Therapeutics Product Offered
Table 78. Bausch Health Companies Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Bausch Health Companies Main Business
Table 80. Bausch Health Companies Latest Developments
Table 81. Mylan Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 82. Mylan Seasonal Affective Disorder Therapeutics Product Offered
Table 83. Mylan Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Mylan Main Business
Table 85. Mylan Latest Developments
Table 86. Sanofi Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 87. Sanofi Seasonal Affective Disorder Therapeutics Product Offered
Table 88. Sanofi Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Sanofi Main Business
Table 90. Sanofi Latest Developments
Table 91. Novartis Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 92. Novartis Seasonal Affective Disorder Therapeutics Product Offered
Table 93. Novartis Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Novartis Main Business
Table 95. Novartis Latest Developments
Table 96. Johnson & Johnson Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 97. Johnson & Johnson Seasonal Affective Disorder Therapeutics Product Offered
Table 98. Johnson & Johnson Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Johnson & Johnson Main Business
Table 100. Johnson & Johnson Latest Developments
Table 101. Koninklijke Philips Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 102. Koninklijke Philips Seasonal Affective Disorder Therapeutics Product Offered
Table 103. Koninklijke Philips Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Koninklijke Philips Main Business
Table 105. Koninklijke Philips Latest Developments
Table 106. Beurer GmbH Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 107. Beurer GmbH Seasonal Affective Disorder Therapeutics Product Offered
Table 108. Beurer GmbH Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Beurer GmbH Main Business
Table 110. Beurer GmbH Latest Developments
Table 111. Lucimed (Luminette) Details, Company Type, Seasonal Affective Disorder Therapeutics Area Served and Its Competitors
Table 112. Lucimed (Luminette) Seasonal Affective Disorder Therapeutics Product Offered
Table 113. Lucimed (Luminette) Seasonal Affective Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Lucimed (Luminette) Main Business
Table 115. Lucimed (Luminette) Latest Developments
LIST OF FIGURES
Figure 1. Seasonal Affective Disorder Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Seasonal Affective Disorder Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Seasonal Affective Disorder Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Seasonal Affective Disorder Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Seasonal Affective Disorder Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Seasonal Affective Disorder Therapeutics Market Size Market Share by Type in 2024
Figure 10. Seasonal Affective Disorder Therapeutics in Hospitals
Figure 11. Global Seasonal Affective Disorder Therapeutics Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Seasonal Affective Disorder Therapeutics in Clinics
Figure 13. Global Seasonal Affective Disorder Therapeutics Market: Clinics (2020-2025) & ($ millions)
Figure 14. Seasonal Affective Disorder Therapeutics in Others
Figure 15. Global Seasonal Affective Disorder Therapeutics Market: Others (2020-2025) & ($ millions)
Figure 16. Global Seasonal Affective Disorder Therapeutics Market Size Market Share by Application in 2024
Figure 17. Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Player in 2024
Figure 18. Global Seasonal Affective Disorder Therapeutics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Seasonal Affective Disorder Therapeutics Market Size 2020-2025 ($ millions)
Figure 20. APAC Seasonal Affective Disorder Therapeutics Market Size 2020-2025 ($ millions)
Figure 21. Europe Seasonal Affective Disorder Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Americas Seasonal Affective Disorder Therapeutics Value Market Share by Country in 2024
Figure 24. United States Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Seasonal Affective Disorder Therapeutics Market Size Market Share by Region in 2024
Figure 29. APAC Seasonal Affective Disorder Therapeutics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Seasonal Affective Disorder Therapeutics Market Size Market Share by Application (2020-2025)
Figure 31. China Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Seasonal Affective Disorder Therapeutics Market Size Market Share by Country in 2024
Figure 38. Europe Seasonal Affective Disorder Therapeutics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Seasonal Affective Disorder Therapeutics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 54. APAC Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 55. Europe Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. United States Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Canada Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. China Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Japan Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Korea Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. India Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Australia Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Germany Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. France Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. UK Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Italy Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Russia Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Israel Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Global Seasonal Affective Disorder Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Seasonal Affective Disorder Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 1. Seasonal Affective Disorder Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Seasonal Affective Disorder Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Seasonal Affective Disorder Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Seasonal Affective Disorder Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Seasonal Affective Disorder Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Seasonal Affective Disorder Therapeutics Market Size Market Share by Type in 2024
Figure 10. Seasonal Affective Disorder Therapeutics in Hospitals
Figure 11. Global Seasonal Affective Disorder Therapeutics Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Seasonal Affective Disorder Therapeutics in Clinics
Figure 13. Global Seasonal Affective Disorder Therapeutics Market: Clinics (2020-2025) & ($ millions)
Figure 14. Seasonal Affective Disorder Therapeutics in Others
Figure 15. Global Seasonal Affective Disorder Therapeutics Market: Others (2020-2025) & ($ millions)
Figure 16. Global Seasonal Affective Disorder Therapeutics Market Size Market Share by Application in 2024
Figure 17. Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Player in 2024
Figure 18. Global Seasonal Affective Disorder Therapeutics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Seasonal Affective Disorder Therapeutics Market Size 2020-2025 ($ millions)
Figure 20. APAC Seasonal Affective Disorder Therapeutics Market Size 2020-2025 ($ millions)
Figure 21. Europe Seasonal Affective Disorder Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Americas Seasonal Affective Disorder Therapeutics Value Market Share by Country in 2024
Figure 24. United States Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Seasonal Affective Disorder Therapeutics Market Size Market Share by Region in 2024
Figure 29. APAC Seasonal Affective Disorder Therapeutics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Seasonal Affective Disorder Therapeutics Market Size Market Share by Application (2020-2025)
Figure 31. China Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Seasonal Affective Disorder Therapeutics Market Size Market Share by Country in 2024
Figure 38. Europe Seasonal Affective Disorder Therapeutics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Seasonal Affective Disorder Therapeutics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Seasonal Affective Disorder Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 54. APAC Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 55. Europe Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. United States Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Canada Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. China Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Japan Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Korea Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. India Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Australia Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Germany Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. France Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. UK Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Italy Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Russia Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Israel Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Global Seasonal Affective Disorder Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Seasonal Affective Disorder Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Seasonal Affective Disorder Therapeutics Market Size 2026-2031 ($ millions)
More Publications
Global Seasonal Affective Disorder Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
US$ 3,480.00
October 2018
116 pages
